RxAll

What they do:

RxAll is building the digital operating system for African pharmacies, using AI and data intelligence to transform how medicines are authenticated, financed, and distributed across emerging markets.

RxAll combines deep technology with local insight to tackle one of Africa’s most pressing healthcare challenges — counterfeit and substandard medicines. Its core product suite includes:

• RxScanner – an AI-enabled molecular sensor that authenticates medicines in seconds with near-perfect accuracy.

• RxDelivered – an e-commerce marketplace connecting pharmacies directly to verified wholesalers and manufacturers.

• RxPay – a financing platform offering trade credit to pharmacies to ensure consistent access to legitimate, affordable stock.

The company has expanded its ecosystem with tools like RxPOS for sales and inventory management, RxAPI for digital pharmacy integration, and RxAcademy, which trains and finances new pharmacy entrepreneurs. Today, RxAll partners with over 5,000 pharmacies, reaching millions of patients each month and providing a reliable, transparent supply chain for essential medicines across Nigeria, Kenya, and Uganda.

Why we invested:

Across the continent, independent pharmacies remain the first point of care for most patients, yet they face systemic barriers such as counterfeit supply chains, financing gaps, and fragmented digital infrastructure. RxAll’s platform directly empowers these pharmacies by combining authentication, trade, and credit into one seamless digital system.

What makes RxAll especially compelling is its fusion of AI innovation and on-the-ground scalability. The company’s technology not only detects falsified medicines but also unlocks new financial and data insights that improve access, reduce waste, and strengthen local healthcare systems.

The Total Addressable Market (TAM) for an “Amazon of Drugs” is approximately USD 1.25Tn. In Nigeria alone, the total available market for drugs is approximately USD 2Bn, which RxDelivered is focused on capturing in the short term, while in the long term, targeting the global healthcare drug market, which suffers from falsified drugs and mislabelling with varying degrees.

The Founder:

Adebayo Alonge, a 2x founder and CEO of RxAll and StorsApp, has over 15 years of experience scaling multimillion-dollar businesses in fintech and healthtech. Leveraging deepTech and DeFi, his platforms enhance access to quality medicines and working capital for small businesses in emerging markets. A Yale and Harvard University-trained professional in finance, business, public policy, and pharmaceutical sciences, Adebayo is a recipient of prestigious awards and fellowships. Passionate about empowering African businesses, he's a global pioneer in combating counterfeit medicines using AI. With a proven track record in fundraising, sales, and product innovation, Adebayo has raised over $11M and launched award-winning solutions.

Active in:

Nigeria